Press Releases

AAHP Mourns the Loss of Dr. Peter Fisher

August 16, 2018

AAHP, along with the global homeopathic community, is shocked and saddened to learn of the tragic and untimely death of Dr. Peter Fisher. A champion of homeopathic medicine, Peter was the director of Research at the Royal London Hospital for Integrated Medicine, Europe’s largest center for integrative medicine. He was also Physician to Her Majesty…

Homeopathic Industry Mourns John A. Borneman, III

July 13, 2018

MILWAUKIE, Ore., July 13, 2018 — The American Association of Homeopathic Pharmacists (AAHP) mourns the loss of an industry legend. John A. (Jack) Borneman, III, grandson of one of the founding members of AAHP, passed away on July 9, 2018. Among the many industry leadership positions he held, Borneman was an integral member of AAHP…

Homeopathic Manufacturers Campaign Sends 38,000 Letters to Capitol Hill

June 27, 2018

MILWAUKIE, Ore., June 27, 2018 — As the result of the American Association of Homeopathic Pharmacists’ (AAHP) first grassroots effort, 38,000 letters from consumers and health care providers poured into offices of U.S. senators and representatives this spring. The letter-writing campaign urged Congressional leaders to ask the U.S. Food and Drug Administration (FDA) to incorporate…

Homeopathic Manufacturers Announce New Disclaimer and Celebrate Momentum at Annual Meeting

May 2, 2018

MILWAUKIE, Ore., May 2, 2018 — The American Association of Homeopathic Pharmacists (AAHP) has announced that all homeopathic manufacturers are now encouraged to use the association’s newly researched and tested package disclaimer. AAHP commissioned a third-party professor of marketing from a prominent university in 2017 to conduct research on the proposed disclaimer. That research provides…

AAHP Shares FDA’s Commitment to Protecting Public Health

December 20, 2017

December 19, 2017 In response to the U.S. Food and Drug Administration’s (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017, the American Association of Homeopathic Pharmacists offers the following statement: The American Association of Homeopathic Pharmacists (AAHP) shares the FDA’s commitment to protecting public health and applauds the Agency’s plan to take…

Upcoming Webinar to Highlight Homeopathic Drug Stability

November 14, 2017

MILWAUKIE, Ore. (Nov. 14, 2017) – The American Association of Homeopathic Pharmacists (AAHP) will host a two-part webinar series on stability studies for homeopathic drug products. Slated for Dec. 4 and Dec. 11, 2017, both from 1:00 – 2:00 p.m. ET, the webinars will be led by Pejman Parhami, senior director of quality systems for…

AAHP Highlights Expanded Homeopathic Drug Manufacturing Best Practices

July 20, 2017

MILWAUKIE, Ore. (July 20, 2017) – The American Association of Homeopathic Pharmacists (AAHP) recently hosted a webinar on 2017 improvements to the Homeopathic Pharmacopeia of the United States (HPUS). Highlighting new manufacturing best practices in the HPUS—which more than tripled to 175 from 40 in the prior version—the webinar underscored how this extensive resource can…

Homeopathic Manufacturers Explore Next-Generation Quality Control

May 4, 2017

MILWAUKIE, Ore., May 4, 2017 — Member companies of the American Association of Homeopathic Pharmacists (AAHP) gathered to learn about promising new technologies recently used by the U.S. Food and Drug Administration (FDA) to analyze homeopathic products. Developments in this area could lead to industry-wide manufacturing advancements as well as improvements to the homeopathic drugs…

AAHP Recognized as Voice of Homeopathy on Capitol Hill

April 10, 2017

MILWAUKIE, Ore., Apr. 10, 2017 — The American Association of Homeopathic Pharmacists’ (AAHP) Legal & Regulatory Committee recently received the 2017 Henry N. Williams Professional Service Award from the National Center for Homeopathy (NCH). Presented on April 1 during the 2017 Joint American Homeopathic Conference, the award honors the committee’s efforts in working with the…

Manufacturers of Homeopathic Medicines Review FDA Test Results and New Application of Technology

February 15, 2017

MILWAUKIE, Ore., Feb. 14, 2017 — The U.S. Food and Drug Administration (FDA) announced on Jan. 27 that its laboratory analysis found inconsistent levels of some specific constituents in certain homeopathic teething tablets. While the industry fully supports and shares the agency’s efforts to safeguard public health, the American Association of Homeopathic Pharmacists (AAHP) cautions…

Leave a Comment

You must be logged in to post a comment.